Pharmacokinetics, systemic toxicity, and acute behavioural effects of the phenethylamine derivative 25E-NBOH in rats
Authors: Hruba, Anezka; Brejtr, Vojtech; Palivec, Petr; Vagnerova, Magdalena; Jurasek, Bronislav; Kalina, Petr; Frkova, Zuzana; Miniarikova, Nina; Ladislavova, Lucie; Aleksic, Kristyna; Mazochova, Kristyna; Duskova, Valentyna; Charalambous, Chrysostomos; Sichova, Klara; Palenicek, Tomas; Kuchar, Martin
Source journal: Neuropharmacology (2026-11-19)
DOI: 10.1016/j.neuropharm.2026.111257
Abstract
25E-NBOH (N-(2'-hydroxybenzyl)-4-ethyl-2,5-dimethoxyphenethylamine) is a potent 5-HT(2A) receptor agonist of the N-benzylphenethylamine (NBOH) family that has recently emerged on the recreational drug market. Despite a documented case of severe human intoxication and the known lethality of closely related NBOMe analogues, an integrated preclinical profile of 25E-NBOH remains lacking. We therefore investigated its pharmacokinetics, systemic toxicity, neuronal cytotoxicity and behavioural effects in rats. In male Wistar rats, serum and brain levels of 25E-NBOH and phase-I metabolites were quantified by LC-MS/MS over 24 h (5 mg/kg, s.c.). Acute toxicity was assessed in females using OECD 423, and neuronal cytotoxicity in primary cortical cultures by MTS assay (0.01- 500 muM, 24 h). Behavioural effects were evaluated at 0.2, 1 and 5 mg/kg s.c. (15 and 60 min after administration), all of which exceed doses associated with recreational use. 25E-NBOH was rapidly absorbed (serum C(max) within 5 min), with peak brain levels at 1 h and a brain/serum AUC ratio of 8.5. The elimination half-life was 3.2 h. Two demethylated metabolites also crossed the blood-brain barrier (brain/serum AUC 6.8-8.4). Systemic toxicity corresponded to GHS Category 3 (LD(50) approximately 200 mg/kg). In vitro cytotoxicity was moderate (IC(50) = 32.4 muM). All three doses produced dose-dependent suppression of locomotion, increased thigmotaxis, and disrupted PPI, persisting at the 60-min onset. At high doses, 25E-NBOH caused marked behavioural suppression and acute systemic toxicity, highlighting potential risks associated with overdose.
Related topics
Related open access articles
- Emerging mycotoxins in botanicals: benefit and risk
- A Brief Review on Core/shell Quantum Dots
- In vitro cytotoxicity studies on galactosylated chitosan nanoparticles for the delivery of oridonin to liver
- Separation of Six Lupane-Type Triterpenoid Saponins from Leaves of Acanthopanax gracilistylus by HSCCC with Preparative-HPLC
- Chemical characterization of polyphenol extracts from Andean and industrial Solanum tuberosum tubers and their cytotoxic activity on human hepatocarcinoma cells
- Effects of Stresses on the Growth and Cytotoxicity of Shiga-Toxin Producing Escherichia coli in Ground Beef and Spinach
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.